However, people will have to wait a little longer as it will not be available in the UK until May 2006. Inhaled insulin will not be appropriate for all people with diabetes, and those people taking long-acting insulin will have to continue to inject it. "Being able to replace some of the daily insulin injections with an inhaler will be a great breakthrough for some people with Type 1 and Type 2 diabetes. It could prove to be one of the biggest steps forward since the discovery of insulin in 1922," said Simon O’Neill, Director of Care at Diabetes UK.“We are pleased that after a thorough investigation of the safety and efficacy information available, the EMEA has said that the product can be marketed.
"We hope that when the National Institute of Clinical Excellence (NICE) comes to review inhaled insulin, it takes into account the potential benefits to people’s quality of life.”